IMGM Laboratories

IMGM Laboratories is a well-established, privately-held German CRO providing specialized genomic services to the life sciences industry. Its core expertise lies in molecular genetics, medical diagnostics, and high-throughput sequencing, with key service pillars in metagenomics, pharmacogenetics, biomarker discovery, and GLP-compliant biodistribution studies. The company operates on a fee-for-service business model, catering to academic, biotech, and pharma clients with a focus on flexibility, quality assurance, and comprehensive data analysis. With over two decades of experience, IMGM positions itself as a trusted outsourcing partner for complex genomic projects.

Flexible portfolio of state-of-the-art genomic technologies including NGS, high-throughput genotyping, qPCR/ddPCR, and integrated bioinformatics analysis. Technology-agnostic approach tailored to client project needs.

IMGM competes in a fragmented market against large, global CROs (e.g., LabCorp, Charles River, ICON) that offer broad service portfolios and against numerous smaller, specialized genomics service providers. Its differentiation lies in its deep expertise in molecular genetics, flexible technology approach, and a strong niche in GLP-compliant biodistribution studies for advanced therapies.